These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 28043871)
1. Bcl-2 inhibitors reduce steroid-insensitive airway inflammation. Tian BP; Xia LX; Bao ZQ; Zhang H; Xu ZW; Mao YY; Cao C; Che LQ; Liu JK; Li W; Chen ZH; Ying S; Shen HH J Allergy Clin Immunol; 2017 Aug; 140(2):418-430. PubMed ID: 28043871 [TBL] [Abstract][Full Text] [Related]
2. Induction of neutrophil apoptosis by a Bcl-2 inhibitor reduces particulate matter-induced lung inflammation. Geng X; Wang X; Luo M; Xing M; Wu Y; Li W; Chen Z; Shen H; Ying S Aging (Albany NY); 2018 Jun; 10(6):1415-1423. PubMed ID: 29944468 [No Abstract] [Full Text] [Related]
3. Inflammatory signatures for eosinophilic vs. neutrophilic allergic pulmonary inflammation reveal critical regulatory checkpoints. Bogaert P; Naessens T; De Koker S; Hennuy B; Hacha J; Smet M; Cataldo D; Di Valentin E; Piette J; Tournoy KG; Grooten J Am J Physiol Lung Cell Mol Physiol; 2011 May; 300(5):L679-90. PubMed ID: 21335522 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of IL-17A neutralization with corticosteroid treatment in a model of antigen-driven mixed-granulocytic asthma. Menson KE; Mank MM; Reed LF; Walton CJ; Van Der Vliet KE; Ather JL; Chapman DG; Smith BJ; Rincon M; Poynter ME Am J Physiol Lung Cell Mol Physiol; 2020 Oct; 319(4):L693-L709. PubMed ID: 32783616 [TBL] [Abstract][Full Text] [Related]
5. Nanoformulated ABT-199 to effectively target Bcl-2 at mitochondrial membrane alleviates airway inflammation by inducing apoptosis. Tian BP; Li F; Li R; Hu X; Lai TW; Lu J; Zhao Y; Du Y; Liang Z; Zhu C; Shao W; Li W; Chen ZH; Sun X; Chen X; Ying S; Ling D; Shen H Biomaterials; 2019 Feb; 192():429-439. PubMed ID: 30500724 [TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharides promote a shift from Th2-derived airway eosinophilic inflammation to Th17-derived neutrophilic inflammation in an ovalbumin-sensitized murine asthma model. Zhao S; Jiang Y; Yang X; Guo D; Wang Y; Wang J; Wang R; Wang C J Asthma; 2017 Jun; 54(5):447-455. PubMed ID: 27589490 [TBL] [Abstract][Full Text] [Related]
7. CXCR1 and CXCR2 Inhibition by Ladarixin Improves Neutrophil-Dependent Airway Inflammation in Mice. Mattos MS; Ferrero MR; Kraemer L; Lopes GAO; Reis DC; Cassali GD; Oliveira FMS; Brandolini L; Allegretti M; Garcia CC; Martins MA; Teixeira MM; Russo RC Front Immunol; 2020; 11():566953. PubMed ID: 33123138 [TBL] [Abstract][Full Text] [Related]
8. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. van Delft MF; Wei AH; Mason KD; Vandenberg CJ; Chen L; Czabotar PE; Willis SN; Scott CL; Day CL; Cory S; Adams JM; Roberts AW; Huang DC Cancer Cell; 2006 Nov; 10(5):389-99. PubMed ID: 17097561 [TBL] [Abstract][Full Text] [Related]
9. Murine model of steroid-resistant neutrophilic bronchial asthma as an attempt to simulate human pathology. Shilovskiy Igor P; Nikolskii Aleksandr A; Kovchina Valeriya I; Vishniakova Lyudmila I; Yumashev Kirill V; Barvinskaia Ekaterina D; Kaganova Mariya M; Korneev Artem V; Turenko Vladislav N; Brylina Vera E; Petukhova Olga A; Kudlay Dmitry A; Khaitov Musa R J Immunol Methods; 2022 Jun; 505():113268. PubMed ID: 35421364 [TBL] [Abstract][Full Text] [Related]
10. Anti-allergic and anti-inflammatory effects of the Bcl-2 inhibitor ABT-737 on experimental allergic rhinitis models. Kim HY; Jeong HJ; Kim HM Eur J Pharmacol; 2018 Aug; 833():34-43. PubMed ID: 29856968 [TBL] [Abstract][Full Text] [Related]
11. The novel Bcl-2 inhibitor ABT-737 is more effective in hypoxia and is able to reverse hypoxia-induced drug resistance in neuroblastoma cells. Klymenko T; Brandenburg M; Morrow C; Dive C; Makin G Mol Cancer Ther; 2011 Dec; 10(12):2373-83. PubMed ID: 22006676 [TBL] [Abstract][Full Text] [Related]
12. Sulforaphane treatment reverses corticosteroid resistance in a mixed granulocytic mouse model of asthma by upregulation of antioxidants and attenuation of Th17 immune responses in the airways. Al-Harbi NO; Nadeem A; Ahmad SF; AlThagfan SS; Alqinyah M; Alqahtani F; Ibrahim KE; Al-Harbi MM Eur J Pharmacol; 2019 Jul; 855():276-284. PubMed ID: 31100413 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Bruton's tyrosine kinase and IL-2 inducible T-cell kinase suppresses both neutrophilic and eosinophilic airway inflammation in a cockroach allergen extract-induced mixed granulocytic mouse model of asthma using preventative and therapeutic strategy. Nadeem A; Ahmad SF; Al-Harbi NO; Ibrahim KE; Siddiqui N; Al-Harbi MM; Attia SM; Bakheet SA Pharmacol Res; 2019 Oct; 148():104441. PubMed ID: 31505252 [TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of the sensitivity of dormant AML cells to the BAD mimetics ABT-199 and ABT-737. Yu N; Seedhouse C; Russell N; Pallis M Leuk Lymphoma; 2018 Oct; 59(10):2447-2453. PubMed ID: 29431553 [TBL] [Abstract][Full Text] [Related]
15. Ex vivo activity of BCL-2 family inhibitors ABT-199 and ABT-737 combined with 5-azacytidine in myeloid malignancies. Bogenberger JM; Delman D; Hansen N; Valdez R; Fauble V; Mesa RA; Tibes R Leuk Lymphoma; 2015 Jan; 56(1):226-9. PubMed ID: 24707940 [No Abstract] [Full Text] [Related]
16. Double-stranded RNA evokes exacerbation in a mouse model of corticosteroid refractory asthma. De Alba J; Otal R; Calama E; Domenech A; Prats N; Gozzard N; Miralpeix M; Clin Sci (Lond); 2015 Dec; 129(11):973-87. PubMed ID: 26245201 [TBL] [Abstract][Full Text] [Related]
17. Transcription factors GATA-3 and RORγt are important for determining the phenotype of allergic airway inflammation in a murine model of asthma. Ano S; Morishima Y; Ishii Y; Yoh K; Yageta Y; Ohtsuka S; Matsuyama M; Kawaguchi M; Takahashi S; Hizawa N J Immunol; 2013 Feb; 190(3):1056-65. PubMed ID: 23293351 [TBL] [Abstract][Full Text] [Related]
18. ABT-737 is a useful component of combinatory chemotherapies for chronic myeloid leukaemias with diverse drug-resistance mechanisms. Kuroda J; Kimura S; Andreeff M; Ashihara E; Kamitsuji Y; Yokota A; Kawata E; Takeuchi M; Tanaka R; Murotani Y; Matsumoto Y; Tanaka H; Strasser A; Taniwaki M; Maekawa T Br J Haematol; 2008 Jan; 140(2):181-90. PubMed ID: 18028486 [TBL] [Abstract][Full Text] [Related]
19. Development of a novel severe triple allergen asthma model in mice which is resistant to dexamethasone and partially resistant to TLR7 and TLR9 agonist treatment. Duechs MJ; Tilp C; Tomsic C; Gantner F; Erb KJ PLoS One; 2014; 9(3):e91223. PubMed ID: 24618687 [TBL] [Abstract][Full Text] [Related]
20. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice. Anstee NS; Bilardi RA; Ng AP; Xu Z; Robati M; Vandenberg CJ; Cory S Cell Death Differ; 2019 Jul; 26(7):1316-1331. PubMed ID: 30470795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]